Inverse dose proportionality: using breakthrough pain medication as a biological indicator for background analgesia escalation.

Authors

Sebastiano Mercadante, Giuseppe Massimo Bellavia, Daniele Napolitano, Alessio Lo Cascio

Published in

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. Volume 34. Issue 9. Aug 20, 2026. Epub Aug 20, 2026.

Abstract

To propose a "top-down" pharmacological hypothesis where the effective dose of rapid-onset opioids (ROOs) for breakthrough pain (BTP) serves as a mathematical predictor for required background analgesic adjustments.
We analyzed five opioid-tolerant cancer patients in a home-care setting with uncontrolled background pain. Instead of traditional reactive titration, a 1:6 inverse proportionality rule was applied, using the patient-identified effective BTP dose to calculate the new around-the-clock (ATC) dose.
Rapid pain stabilization was achieved in patients within 24-48 h. Despite significant dose escalations (up to 300%), no clinical signs of opioid-induced neurotoxicity or respiratory depression were observed.
The effective BTP dose may act as a "bio-indicator" of systemic opioid requirement. This hypothesis challenges the "start low, go slow" dogma, suggesting a more aggressive, patient-centered titration model that warrants formal prospective validation.

PMID:
42622864
Bibliographic data and abstract were imported from PubMed on 21 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.